This message contains images. If you don't see images, click here to view.
Click here to advertise in this news brief.

  Mobile version   RSS   Subscribe   Unsubscribe
Home    About    Scholarships    Meetings    Publications    Resources    Join ASCLS July 19, 2011
ASCLS eNewsBytes
July 19, 2011
ASCLS Quick Links >   Home    About    Scholarships    Meetings    Publications    Resources

Clinically relevant changes in family history of cancer over time
The Journal of the American Medical Association    Share    Share on FacebookTwitterShare on LinkedinE-mail article
To assist with assessment and cancer prevention screening guides, Ziogas and colleagues examined baseline and family history data from participants with a personal or family history of cancer. In an editorial, Acheson discusses the importance of changes in family history for cancer prevention. Knowledge of family cancer history is important for assessing cancer risk and guiding screening recommendations. More

Disruptive behavior
Clinical Laboratory News    Share    Share on FacebookTwitterShare on LinkedinE-mail article
In the laboratory, producing accurate and timely patient test results depends on teamwork, communication and a collaborative work environment. However, laboratory staff who display intimidating and disruptive behaviors can quickly destabilize this cooperative environment and negatively impact patient safety. The Joint Commission advises health care organizations to confront behavior problems in order to promote a culture of safety and efficient team performance. More

Qualiris by Stago

Qualiris by Stago is a Web-based External Quality Assessment program used to provide enhanced confidence for your hemostasis testing. Qualiris provides peer-group, result comparisons from a global to a local level. Stago's dedicated experts are available 24/7 to help interpret your results. For more information on Quadfsliris visit

Accusations fly over obscure Medicare board
The Associated Press via Google News    Share    Share on FacebookTwitterShare on LinkedinE-mail article
An independent panel authorized by President Barack Obama's health care law to control excessive Medicare cost increases is drawing heavy fire from Republicans. Nearly every health industry lobbying group is pushing for its repeal, as are some consumer advocates. GOP lawmakers call it a rationing panel, and at least one has suggested seniors will die from its decisions. More

Specialists in Bone, Growth, Cartilage, Hypertension & Automation

IDS manufactures and markets specialist Immunoassays for diagnostic and research laboratory testing. These include fully automated and manual assays.

It's back on the table — Medicare patient co-pay for clinical laboratory tests is 1 of 27 cost-cutting proposals in federal debt ceiling negotiations
DarkDaily    Share    Share on FacebookTwitterShare on LinkedinE-mail article
Spending cuts of between $334 billion and $353 billion over the next 10 years are on the table in the negotiations over the federal debt ceiling. The bad news for the clinical laboratory industry is that restoration of the Medicare patient co-pay for medical laboratory tests is not only on the list of proposed spending cuts, but represents a significant chunk of money—as much as $16 billion during the next decade. More

Stem cell technique produces colonies of blood cells from patient's existing cells
DailyTech    Share    Share on FacebookTwitterShare on LinkedinE-mail article
The technique still needs work, but the team identified blood-specific markers on 84 percent of the cells after three weeks, which is a large leap in efficiency compared to a few years ago. Researchers have found a way to produce increased numbers of blood cells from a patient's existing cells through an improved stem cell technique. More

A breath of fresh air in diagnostics

Providing the accurate, dependable allergy, urinalysis and auto-immune results you require. Delivering the cost-effective test results you value.

Cancer diagnoses in ages 40-59 soar 20 percent in a generation
The Guardian    Share    Share on FacebookTwitterShare on LinkedinE-mail article
Cancer diagnoses in middle-aged men and women have soared by 20 percent in a generation as screening picks up more cases and smoking, drinking, obesity and unfitness continue to take a toll. A steep rise in cancer rates among people aged 40 to 59 since 1979 has resulted in an extra 17,000 cancers being diagnosed every year. More

Low-carbohydrate, high-protein diets may reduce both tumor growth rates and cancer risk
ScienceDaily    Share    Share on FacebookTwitterShare on LinkedinE-mail article
Eating a low-carbohydrate, high-protein diet may reduce the risk of cancer and slow the growth of tumors already present, according to a study published in Cancer Research, a journal of the American Association for Cancer Research. More

At Phadia®, we see things differently.

See what we see. For cutting-edge testing technologies for allergic and autoimmune diseases… Look no further than Phadia. Contact us today at 800.346.4364 or

65-year-old baby boomers ready to fight for right to opt out of Medicare
DarkDaily    Share    Share on FacebookTwitterShare on LinkedinE-mail article
Will the oldest Baby Boomers, now turning 65-years-old, accept enrollment in the Medicare program or will they challenge it, as they have challenged many other institutions in American society over their lifetimes? News outlets are already reporting instances of Baby Boomers fighting to keep their existing private health insurance. More

Innovative Tumor Marker/Vitamin D Products

Visit Fujirebio Diagnostics, Inc. at the AACC in Atlanta, Booth# 2221 and learn more about HE4 and CYFRA 21-1™ EIA assays in addition to Tumor Marker and Vitamin D Controls! MORE

Treatment, not medicine, helps asthma patients feel better
Reuters Life    Share    Share on FacebookTwitterShare on LinkedinE-mail article
The New England Journal of Medicine demonstrates the importance of, literally, caring for patients and not just providing drugs. The findings also demonstrate the impact of the so-called "placebo effect," or the phenomenon seen in clinical trials when people given inactive, fake "treatments," such as a sugar pill or saline, show improvements. More
Triturus - True Open Flexibility
As a leader in fully automated immunoassay testing systems, Grifols USA Diagnostic Division’s premier product, the TRITURUS® ELISA System is an open, fully automated, multi-test and multi-batch immunoassay system. Grifols USA is a major distributor of quality IVD ELISA tests for Infectious Disease, Autoimmune Diseases and many other disease states. Grifols’ Diagnostic products take the complexity out of clinical diagnostic testing.

Contact us at 1-800-379-0957.
CellaVision Automates and Standardizes the Manual Differential

CellaVision introduces CellAtlas®, the perfect way to learn the basics of hematology cell morphology. This App for the Apple iPhone and iPod Touch compliments our digital cell morphology portfolio, and is an educational tool to assist in the recognition and classification of blood cells, by utilizing mini-lectures and cell quizzes. More
Trust in Cleveland Clinic Laboratories
Cleveland Clinic Laboratories is a full-service, national reference lab dedicated to providing world class care. We have a dedicated staff of more than 1,300 employees, including board-certified subspecialty pathologists, PhDs, technologists, technicians, and support personnel. Cleveland Clinic Laboratories is proud to serve hospitals, outpatient facilities and physician offices worldwide. For more information, please visit
This edition of the ASCLS eNewsBytes was sent to ##Email##. To unsubscribe, click here.

Did someone forward this edition to you? Subscribe here - it's free!


Colby Horton, Vice President of Publishing

Download Media Kit

To contribute news to the ASCLS eNewsBytes, contact Yvette Craig, Senior Content Editor

Recent Issues

  • July 12, 2011
  • July 5, 2011
  • June 28, 2011
  • June 21, 2011
  • June 14, 2011
  •  RSS Feed
    Most popular articles